Asia's leading research services organization GVK Biosciences has entered into a strategic alliance with US-based Quantitative Solutions (QS) to develop and market clinical trial outcome data base.

Under the agreed terms, GVK Biosciences will distribute Quantitative Solutions' existing data base in five therapeutic areas. QS is a leading scientific consultancy to the pharmaceutical and biotech industry.

A company official stated in a release that Indian firm would market the existing data base of the American company in therapeutic areas such as rheumatoid arthritis and psoriasis, chronic HCV, neuropathic pain, osteoporosis and major depressions.

Apart from this, GVK and QS has planned to jointly develop and market additional databases in dyslipodemia, schizophrenia, Alzheimer's and in other areas shortly.